Kiniksa Pharmaceuticals International, plc (KNSA)
(Delayed Data from NSDQ)
$35.77 USD
-0.79 (-2.16%)
Updated Sep 16, 2025 04:00 PM ET
After-Market: $35.74 -0.03 (-0.08%) 7:58 PM ET
1-Strong Buy of 5 1
D Value A Growth D Momentum B VGM
Fundamental Charts
About Earnings Yield (TTM)
The company's trailing twelve month (TTM) Earning Yield is used to determine whether the company is undervalued or overvalued. The Earning yield an indicator of the company's earnings and the price paid for the stock. The calculation is the inverse of the P/E ratio. The most common use of the Earnings ratio is to compare it to other stocks and to compare the yields to the 10 Year T-Bill. If earnings go up, the yield goes up. If earnings go down, so does the yield. For example: If the yield on the S&P 500 is greater than the 10 Year T-Bill, stocks would be considered undervalued.
KNSA 35.77 -0.79(-2.16%)
Will KNSA be a Portfolio Killer in September?
Zacks Investment Research is releasing its prediction for KNSA based on the 1-3 month trading system that more than doubles the S&P 500.
Zacks News for KNSA
Zoetis Gains CVMP Backing for Portela, Eyes EU Approval in Cat OA Pain
RAPP Stock Soars 62% in a Week on Meeting Phase II Epilepsy Study Goal
KNSA: What are Zacks experts saying now?
Zacks Private Portfolio Services
TVTX Stock Soars as FDA Waives Advisory Committee for Filspari sNDA
RARE Reports Positive Long-Term Data From Metabolic Disorder Study
IMVT Stock Up 11% on Upbeat Batoclimab Hyperthyroidism Study Results
Other News for KNSA
Slingshot Bullish appears for KNSA after 1.46% move
Tracking Baker Brothers Portfolio - Q2 2025 Update
KNSA makes New 52 Week Closing High on September 12
Is KNSA positioned for a breakout? New 52 Week Closing High shows up after rising 2.15%
Is KNSA set to rally? New 52 Week High shows up after sliding 1.71%